RBC Bearings
RBC
500.73
-13.45
-2.62%
RBC Bearings
US · RBC
#1093 by market cap
Listed 1970
500.73
-13.45
-2.62%
Live - 5344 symbols - heartbeat 97s ago
· 2026-10-07 19:54
After-hours
500.73
0.00%
- Market cap
- 15.85B
- P/E (TTM)i
- 49.48
- P/Bi
- 4.58
- EPSi
- 9.09
- Div yieldi
- 0.00%
- 52W posi
- 45%
Reader sentiment
Are you bullish or bearish on RBC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.67, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +14.34% YoY
Margins
- Gross margin
- 44.37%
- Operating margin
- 23.09%
- Net margin
- 15.37%
Key ratios & quality
- Enterprise valuei
- 16.69B
- PEG ratioi
- 2.48
- Altman Z-Scorei
- 6.67
PEG uses trailing P/E against the 3-year net income growth rate (19.94%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 702.52M | 727.46M | 609.00M | 942.90M | 1.47B | 1.56B | 1.64B | 1.87B |
| Gross profit | 276.65M | 289.10M | 234.10M | 357.10M | 604.80M | 670.50M | 726.10M | 830.20M |
| Selling & admin expenses | 117.50M | 129.98M | 102.80M | 167.60M | 229.70M | 253.50M | 279.30M | 316.10M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 149.28M | 149.25M | 120.60M | 154.30M | 305.20M | 346.40M | 373.80M | 432.00M |
| Pretax profit | 126.09M | 146.72M | 113.20M | 78.70M | 209.70M | 261.80M | 311.90M | 369.30M |
| Tax | 20.90M | 26.37M | 23.10M | 24.00M | 43.00M | 51.90M | 65.70M | 81.70M |
| Net profit | 105.19M | 120.35M | 90.10M | 54.70M | 166.70M | 209.90M | 246.20M | 287.60M |
| Basic EPS | 4 | 5 | 4 | 2 | 5 | 6 | 8 | 9 |
| Diluted EPS | 4.26 | 4.81 | 3.58 | 1.56 | 4.94 | 6.41 | 7.70 | 9.09 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 437.70M | 436.00M | 455.30M | 461.60M | 518.00M | 519.50M |
| Gross profit | 193.40M | 195.20M | 200.60M | 204.40M | 230.00M | 247.80M |
| Selling & admin expenses | 72.10M | 73.90M | 77.40M | 77.90M | 86.90M | 85.80M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 101.90M | 103.40M | 102.50M | 105.50M | 120.60M | 141.00M |
| Pretax profit | 87.90M | 87.70M | 83.40M | 89.30M | 108.90M | 130.20M |
| Tax | 15.20M | 19.20M | 23.40M | 21.90M | 17.20M | 28.70M |
| Net profit | 72.70M | 68.50M | 60.00M | 67.40M | 91.70M | 101.50M |
| Basic EPS | 2 | 2 | 2 | 2 | 3 | 3 |
| Diluted EPS | 2.30 | 2.17 | 1.90 | 2.13 | 2.89 | 3.20 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 503.28M | 612.01M | 728.20M | 962.20M | 913.30M | 965.50M | 1.03B | 1.19B |
| Cash & ST investments | 29.88M | 103.26M | 241.34M | 182.90M | 65.40M | 63.50M | 36.80M | 57.30M |
| Inventory | 335.00M | 367.49M | 364.15M | 516.10M | 587.20M | 622.80M | 654.50M | 762.80M |
| Total assets | 1.15B | 1.32B | 1.43B | 4.85B | 4.69B | 4.68B | 4.69B | 5.12B |
| Total current liabilities | 90.13M | 103.76M | 88.24M | 313.50M | 309.30M | 294.30M | 315.30M | 546.20M |
| Short-term debt | 467.00K | 12.14M | 8.34M | 13.50M | 14.30M | 16.50M | 16.80M | 190.10M |
| Long-term debt | 43.18M | 16.58M | 13.50M | 1.69B | 1.39B | 1.19B | 918.40M | 701.70M |
| Total liabilities | 178,801,000.00 | 203,913,000.00 | 202,162,000.00 | 2,472,900,000.00 | 2,154,500,000.00 | 1,926,700,000.00 | 1,653,800,000.00 | 1,761,700,000.00 |
| Total equity | 968.57M | 1.12B | 1.23B | 2.37B | 2.54B | 2.75B | 3.03B | 3.36B |
| Retained earnings | 641.89M | 769.22M | 843.46M | 886.10M | 1.03B | 1.22B | 1.45B | 1.74B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.03B | 1.14B | 1.19B | 1.22B | 1.19B | 1.27B |
| Cash & ST investments | 36.80M | 132.90M | 91.20M | 107.60M | 57.30M | 124.50M |
| Inventory | 654.50M | 679.70M | 768.70M | 781.50M | 762.80M | 776.40M |
| Total assets | 4.69B | 4.79B | 5.11B | 5.14B | 5.12B | 5.20B |
| Total current liabilities | 315.30M | 341.30M | 375.10M | 656.40M | 546.20M | 500.70M |
| Short-term debt | 16.80M | 17.10M | 16.70M | 304.10M | 190.10M | 111.90M |
| Long-term debt | 918.40M | 913.80M | 1.07B | 701.60M | 701.70M | 710.00M |
| Total liabilities | 1,653,800,000.00 | 1,673,300,000.00 | 1,923,600,000.00 | 1,880,500,000.00 | 1,761,700,000.00 | 1,734,100,000.00 |
| Total equity | 3.03B | 3.12B | 3.19B | 3.26B | 3.36B | 3.46B |
| Retained earnings | 1.45B | 1.52B | 1.58B | 1.65B | 1.74B | 1.84B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 108.55M | 155.62M | 152.40M | 180.30M | 220.60M | 274.70M | 293.60M | 415.70M |
| Depreciation & amortization | 29.66M | 31.42M | 32.70M | 65.50M | 115.40M | 119.30M | 120.00M | 128.80M |
| Free cash flow | 67.20M | 118.32M | 140.60M | 150.50M | 178.60M | 241.50M | 243.80M | 342.60M |
| Dividends paid | -- | 0 | 0 | -7.10M | -22.90M | -23.00M | -17.20M | 0 |
| Stock buybacks / issuance | -5.23M | -12.21M | -6.80M | 596.90M | -7.70M | -11.00M | -9.50M | -14.40M |
| Ending cash balance | 29.88M | 103.26M | 151.10M | 182.90M | 65.40M | 63.50M | 36.80M | 57.30M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 69.20M | 120.00M | 88.40M | 122.10M | 85.20M | 171.80M |
| Depreciation & amortization | 30.10M | 29.60M | 32.90M | 32.90M | 33.40M | 33.30M |
| Free cash flow | 55.00M | 104.30M | 71.70M | 99.10M | 67.50M | 146.90M |
| Dividends paid | 0 | -- | -- | 0 | 0 | -- |
| Stock buybacks / issuance | -900.00K | -12.10M | -600.00K | -500.00K | -1.20M | -10.70M |
| Ending cash balance | 36.80M | 132.90M | 91.20M | 107.60M | 57.30M | 124.50M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.67 | 12.08 | 7.64 | 2.95 | 5.86 | 7.07 | 8.09 | 9.00 |
| ROA %i | 9.19 | 10.21 | 6.50 | 1.69 | 3.02 | 3.99 | 4.99 | 5.86 |
| ROIC %i | 10.84 | 11.69 | 7.41 | 2.57 | 4.87 | 6.20 | 6.94 | 7.76 |
| 5-year avg ROE %i | 11.02 | 11.18 | 10.53 | 8.89 | 7.82 | 6.90 | 6.21 | 6.48 |
| EBIT margin %i | 18.68 | 21.45 | 18.31 | 11.70 | 19.00 | 21.82 | 22.72 | 22.40 |
| FCF / sales %i | 9.57 | 16.27 | 23.10 | 15.96 | 12.16 | 15.48 | 14.90 | 18.31 |
| Current ratioi | 5.58 | 5.90 | 8.25 | 3.07 | 2.95 | 3.28 | 3.26 | 2.18 |
| Quick ratioi | 1.78 | 2.24 | 3.99 | 1.37 | 0.99 | 1.08 | 1.09 | 0.73 |
| Debt / assetsi | 3.80 | 3.94 | 3.61 | 36.84 | 31.77 | 27.50 | 21.96 | 19.35 |
| LT debt / equityi | 4.46 | 3.58 | 3.53 | 74.67 | 58.20 | 46.15 | 33.39 | 23.84 |
| Interest coveragei | 25.37 | 82.77 | 77.96 | 4.88 | 4.02 | 4.33 | 6.22 | 8.42 |
| Revenue CAGR (3Y) %i | 5.55 | 5.74 | -3.37 | 10.31 | 26.41 | 36.83 | 20.17 | 8.39 |
| Net income CAGR (3Y) %i | 18.08 | 19.44 | 1.12 | -19.59 | 11.47 | 32.57 | 65.11 | 19.94 |
| FCF CAGR (3Y) %i | 2.45 | 13.77 | 11.18 | 30.83 | 14.71 | 19.76 | 17.44 | 24.25 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.09 | 8.33 | 8.50 | 8.66 | 9.00 | 9.75 |
| ROA %i | 4.99 | 5.20 | 5.25 | 5.48 | 5.86 | 6.42 |
| ROIC %i | 6.94 | 7.17 | 7.15 | 7.42 | 7.76 | 8.48 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 22.72 | 22.48 | 22.42 | 22.32 | 22.40 | 23.51 |
| FCF / sales %i | 14.90 | 15.59 | 17.67 | 18.44 | 18.31 | 19.71 |
| Current ratioi | 3.26 | 3.33 | 3.18 | 1.86 | 2.18 | 2.53 |
| Quick ratioi | 1.09 | 1.25 | 0.99 | 0.60 | 0.73 | 0.90 |
| Debt / assetsi | 21.96 | 20.49 | 22.20 | 20.53 | 19.35 | 16.90 |
| LT debt / equityi | 33.39 | 30.94 | 35.08 | 23.04 | 23.84 | 22.13 |
| Interest coveragei | 6.22 | 6.83 | 7.34 | 7.78 | 8.42 | 9.63 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- industrial is the largest reported line at 56.61% of revenue, across 2 reported segments.
- Aerospace/Defense follows at 43.39%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
industrial56.61%
Aerospace/Defense43.39%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.